CUSIP: 45254C101
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,003,261
-
Share change
-
+1,989,669
-
Total reported value
-
$912,000
-
Price per share
-
$0.18
-
Number of holders
-
13
-
Value change
-
+$344,542
-
Number of buys
-
9
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP 45254C101?
CUSIP 45254C101 identifies IMNP - IMMUNE PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2017
-
Previous quarter:
Q3 2016
Recent filing periods for CUSIP 45254C101:
Institutional Holders of IMMUNE PHARMACEUTICALS INC - COM (IMNP) as of Q4 2016
As of 31 Dec 2016,
IMMUNE PHARMACEUTICALS INC - COM (IMNP) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,003,261 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, UBS Group AG, Advisor Group, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, KCG HOLDINGS, INC., GOLDMAN SACHS GROUP INC, LADENBURG THALMANN FINANCIAL SERVICES INC., and Geduld E E.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.